Featured Research

from universities, journals, and other organizations

Regional anesthesia reduces complications and death for hip fracture patients

Date:
June 20, 2012
Source:
Perelman School of Medicine at the University of Pennsylvania
Summary:
In a study of more than 18,000 patients having surgery for hip fracture, researchers found that the use of regional anesthesia versus general anesthesia, was associated with a significant reduction in major pulmonary complications and death.

In a study of more than 18,000 patients having surgery for hip fracture, researchers at the Perelman School of Medicine at the University of Pennsylvania found that the use of regional anesthesia versus general anesthesia, was associated with a significant reduction in major pulmonary complications and death. The new study will be published in the July issue of the journal Anesthesiology.

"Hip fracture is a common and costly event among older adults," said lead study author Mark D. Neuman, MD, assistant professor of Anesthesiology and Critical Care and senior fellow at the Leonard Davis Institute for Health Economics. "One out of five hip fracture patients dies within a year of their injury. There is an urgent need for better information to guide patients and clinicians make decisions about anesthesia for hip fracture surgery, but so far very few large observational studies in the general population have examined this issue."

Hip fractures are a global public health problem, occurring 1.6 million times worldwide, and their incidence is anticipated to grow rapidly during the next three decades because of the aging of the population. Most hip fractures occur in people older than 65, with the mortality and morbidity compilations increasing rapidly after age 80. A hip fracture almost always requires surgical repair or replacement, followed by weeks to months of physical therapy.

Dr. Neuman and his co-authors examined a retrospective cohort of patients undergoing surgery for hip fracture in 126 hospitals in New York in 2007 and 2008, which included a total of 18,158 patients. They tested the association of regional (epidural, spinal or nerve block) versus general anesthesia with inpatient mortality, major inpatient pulmonary complications, and major inpatient cardiovascular complications.

Among patients undergoing hip fracture surgery, the researchers found a 29 percent lower adjusted odds of mortality among patients receiving regional versus general anesthesia. They also found a 24 percent decrease in the adjusted odds of any inpatient pulmonary complication with regional anesthesia.

"These findings have important implications for practice, policy, and research related to the treatment of older adults with hip fracture," said Lee A. Fleisher, MD, chair and Robert Dunning Dripps Professor of Anesthesiology and Critical Care and the senior author of the study. "Given the high rate of mortality associated with hip fracture and the large and growing worldwide public health burden attributed to complications of hip fracture care, our findings highlight an important potential opportunity to improve outcomes among a growing population of vulnerable surgical patients."

The study was funded, in part, by the Foundation for Anesthesia Education and Research (FAER).


Story Source:

The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mark D. Neuman, Jeffrey H. Silber, Nabil M. Elkassabany, Justin M. Ludwig, Lee A. Fleisher. Comparative Effectiveness of Regional versus General Anesthesia for Hip Fracture Surgery in Adults. Anesthesiology, 2012; 117 (1): 72 DOI: 10.1097/ALN.0b013e3182545e7c

Cite This Page:

Perelman School of Medicine at the University of Pennsylvania. "Regional anesthesia reduces complications and death for hip fracture patients." ScienceDaily. ScienceDaily, 20 June 2012. <www.sciencedaily.com/releases/2012/06/120620100827.htm>.
Perelman School of Medicine at the University of Pennsylvania. (2012, June 20). Regional anesthesia reduces complications and death for hip fracture patients. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/06/120620100827.htm
Perelman School of Medicine at the University of Pennsylvania. "Regional anesthesia reduces complications and death for hip fracture patients." ScienceDaily. www.sciencedaily.com/releases/2012/06/120620100827.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins